Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo
- 8 February 2011
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 46 (2) , 269-279
Abstract
Guimarães MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL, Rossa C Jr. Potent anti‐inflammatory effects of systemically administered curcumin modulate periodontal diseasein vivo. J Periodont Res 2011; 46: 269–279. © 2011 John Wiley & Sons A/S Background and Objective: Curcumin is a plant‐derived dietary spice with various biological activities, including anticarcinogenic and anti‐inflammatory effects. Its therapeutic applications have been studied in a variety of conditions, including rheumatoid arthritis, colon cancer and depression, but no studies have evaluated the effects of curcumin on periodontal disease in vivo. Material and Methods: Experimental periodontal disease was induced in rats by placing cotton ligatures around both lower first molars. Curcumin was given to the rats by the intragastric route daily at two dosages (30 and 100 mg/kg) for 15 d. Control animals received ligatures but only the corn oil vehicle by gavage, and no treatment‐negative control animals were included. Bone resorption was assessed by micro‐computed tomography, and the inflammatory status was evaluated by stereometric analysis. Both RT‐qPCR and ELISA were used to determine the expression of interleukin‐6, tumor necrosis factor‐α and prostaglandin E2 synthase in the gingival tissues. Modulation of p38 MAPK and nuclear factor‐κB activation were assessed by western blotting. Results: Bone resorption was effectively induced in the experimental period, but it was not affected by either dose of curcumin. Curcumin effectively inhibited cytokine gene expression at both the mRNA and the protein level and produced a dose‐dependent inhibition of the activation of nuclear factor‐κB in the gingival tissues. Activation of p38 MAPK was not inhibited by curcumin. Curcumin‐treated animals also presented a marked reduction of the inflammatory cell infiltrate and increased collagen content and fibroblastic cell numbers. Conclusion: Curcumin did not prevent alveolar bone resorption, but its potent anti‐inflammatory effect suggests that it may have a therapeutic potential in periodontal diseases.Keywords
This publication has 62 references indexed in Scilit:
- Curcumin modulates the immune response associated with LPS-induced periodontal disease in ratsInnate Immunity, 2011
- MAP Kinase Phosphatase-1 Protects against Inflammatory Bone LossJournal of Dental Research, 2009
- Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitisLife Sciences, 2009
- Novel host response therapeutic approaches to treat periodontal diseasesPeriodontology 2000, 2007
- MKK3/6—p38 MAPK negatively regulates murine MMP-13 gene expression induced by IL-1β and TNF-α in immortalized periodontal ligament fibroblastsMatrix Biology, 2005
- Curcumin: The story so farEuropean Journal of Cancer, 2005
- Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targetsExperimental & Molecular Medicine, 2005
- The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A reviewArchives of Gerontology and Geriatrics, 2002
- Curcumin, an Anti-tumor Promoter and Anti-inflammatory Agent, Inhibits Induction of Nitric Oxide Synthase in Activated MacrophagesBiochemical and Biophysical Research Communications, 1995
- Tissue Levels of Bone Resorptive Cytokines in Periodontal DiseaseJournal of Periodontology, 1991